久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/10 | 3,825 | 3,845 | 3,800 | 3,805 | -75 | -1.9% | 143,600 |
| 2023/03/09 | 3,795 | 3,880 | 3,790 | 3,880 | +105 | +2.8% | 137,800 |
| 2023/03/08 | 3,800 | 3,800 | 3,775 | 3,775 | -25 | -0.7% | 91,400 |
| 2023/03/07 | 3,800 | 3,845 | 3,800 | 3,800 | -35 | -0.9% | 89,400 |
| 2023/03/06 | 3,815 | 3,835 | 3,785 | 3,835 | +20 | +0.5% | 105,900 |
| 2023/03/03 | 3,770 | 3,825 | 3,750 | 3,815 | +40 | +1.1% | 126,200 |
| 2023/03/02 | 3,790 | 3,805 | 3,755 | 3,775 | +10 | +0.3% | 81,800 |
| 2023/03/01 | 3,800 | 3,805 | 3,755 | 3,765 | -55 | -1.4% | 116,300 |
| 2023/02/28 | 3,865 | 3,875 | 3,805 | 3,820 | -75 | -1.9% | 117,800 |
| 2023/02/27 | 3,895 | 3,900 | 3,820 | 3,895 | -35 | -0.9% | 130,900 |
| 2023/02/24 | 3,920 | 3,945 | 3,895 | 3,930 | +10 | +0.3% | 232,000 |
| 2023/02/22 | 3,920 | 3,940 | 3,900 | 3,920 | -40 | -1% | 101,800 |
| 2023/02/21 | 3,930 | 3,975 | 3,930 | 3,960 | +45 | +1.1% | 85,400 |
| 2023/02/20 | 3,910 | 3,915 | 3,885 | 3,915 | +30 | +0.8% | 69,600 |
| 2023/02/17 | 3,855 | 3,905 | 3,855 | 3,885 | -10 | -0.3% | 56,200 |
| 2023/02/16 | 3,905 | 3,950 | 3,885 | 3,895 | ±0 | ±0% | 72,000 |
| 2023/02/15 | 3,920 | 3,920 | 3,875 | 3,895 | -60 | -1.5% | 74,100 |
| 2023/02/14 | 3,990 | 4,010 | 3,925 | 3,955 | +25 | +0.6% | 89,100 |
| 2023/02/13 | 4,000 | 4,000 | 3,905 | 3,930 | -60 | -1.5% | 68,600 |
| 2023/02/10 | 3,970 | 4,035 | 3,955 | 3,990 | -15 | -0.4% | 99,300 |
| 2023/02/09 | 4,000 | 4,045 | 3,995 | 4,005 | -5 | -0.1% | 112,000 |
| 2023/02/08 | 3,950 | 4,025 | 3,950 | 4,010 | +55 | +1.4% | 105,500 |
| 2023/02/07 | 3,895 | 3,975 | 3,895 | 3,955 | +70 | +1.8% | 108,000 |
| 2023/02/06 | 3,955 | 3,955 | 3,875 | 3,885 | -30 | -0.8% | 155,500 |
| 2023/02/03 | 4,000 | 4,005 | 3,880 | 3,915 | -125 | -3.1% | 214,800 |
| 2023/02/02 | 4,030 | 4,065 | 4,020 | 4,040 | +15 | +0.4% | 128,200 |
| 2023/02/01 | 4,050 | 4,065 | 4,025 | 4,025 | -10 | -0.2% | 124,600 |
| 2023/01/31 | 4,000 | 4,040 | 4,000 | 4,035 | +30 | +0.7% | 158,200 |
| 2023/01/30 | 3,985 | 4,015 | 3,970 | 4,005 | +65 | +1.6% | 125,500 |
| 2023/01/27 | 3,975 | 4,000 | 3,940 | 3,940 | -35 | -0.9% | 94,600 |
| 2023/01/26 | 3,990 | 4,005 | 3,970 | 3,975 | +10 | +0.3% | 128,900 |
| 2023/01/25 | 3,950 | 3,980 | 3,925 | 3,965 | +10 | +0.3% | 122,900 |
| 2023/01/24 | 3,935 | 3,985 | 3,915 | 3,955 | +35 | +0.9% | 128,900 |
| 2023/01/23 | 3,900 | 3,965 | 3,875 | 3,920 | +60 | +1.6% | 173,500 |
| 2023/01/20 | 3,830 | 3,895 | 3,820 | 3,860 | +35 | +0.9% | 142,000 |
| 2023/01/19 | 3,860 | 3,880 | 3,815 | 3,825 | -90 | -2.3% | 165,900 |
| 2023/01/18 | 3,850 | 3,915 | 3,820 | 3,915 | +55 | +1.4% | 201,000 |
| 2023/01/17 | 3,810 | 3,885 | 3,795 | 3,860 | +55 | +1.4% | 165,100 |
| 2023/01/16 | 3,825 | 3,830 | 3,735 | 3,805 | -65 | -1.7% | 210,100 |
| 2023/01/13 | 3,735 | 3,890 | 3,725 | 3,870 | +190 | +5.2% | 429,400 |
| 2023/01/12 | 3,665 | 3,705 | 3,660 | 3,680 | +15 | +0.4% | 167,100 |
| 2023/01/11 | 3,645 | 3,700 | 3,640 | 3,665 | +20 | +0.5% | 145,500 |
| 2023/01/10 | 3,655 | 3,675 | 3,620 | 3,645 | +5 | +0.1% | 181,300 |
| 2023/01/06 | 3,670 | 3,685 | 3,635 | 3,640 | -50 | -1.4% | 147,600 |
| 2023/01/05 | 3,725 | 3,735 | 3,690 | 3,690 | -50 | -1.3% | 121,800 |
| 2023/01/04 | 3,915 | 3,915 | 3,740 | 3,740 | -185 | -4.7% | 187,300 |
| 2022/12/30 | 3,915 | 3,965 | 3,915 | 3,925 | +10 | +0.3% | 120,700 |
| 2022/12/29 | 3,900 | 3,915 | 3,880 | 3,915 | +20 | +0.5% | 111,200 |
| 2022/12/28 | 3,850 | 3,915 | 3,835 | 3,895 | +35 | +0.9% | 106,000 |
| 2022/12/27 | 3,855 | 3,900 | 3,855 | 3,860 | +20 | +0.5% | 98,000 |
601～
650
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 428,400円 | +5.8% | +1.2% | 2.80% | 13.87倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 140,700円 | -11.0% | +206.6% | 0.00% | 13.97倍 | 3.30倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 参天薬 | 156,700円 | -2.0% | -7.3% | 2.43% | 15.32倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ツムラ | 361,300円 | +3.8% | -19.9% | 3.76% | 11.74倍 | 0.90倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 322,200円 | +3.6% | -15.3% | 3.85% | 9.05倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
